It slows gastric emptying (leading to early satiety), increases insulin secretion, and signals the brain to reduce appetite
I did not increase my dose I am still taking the starting dose and it still works
However, like any treatment, they do come with some possible side effects
Villumsen M et al
Ohio to end GLP-1 drug weight loss coverage for state workers COLUMBUS, Ohio (WSYX) The Ohio Department of Administrative Services announced that coverage for GLP-1 drugs for weight loss, including Ozempic and Mounjaro, will end for state employees on July 1, 2025
GLP-1 Receptor Agonists and Other Drugs Heres everything you need to know about GLP-1 medications like Ozempic, including benefits, side effects, and how to navigate your options